» Articles » PMID: 35291930

The Fab Portion of Immunoglobulin G Has Sites in the CL Domain That Interact with Fc Gamma Receptor IIIa

Overview
Journal MAbs
Date 2022 Mar 16
PMID 35291930
Authors
Affiliations
Soon will be listed here.
Abstract

The interaction between IgG and Fc gamma receptor IIIa (FcγRIIIa) is essential for mediating immune responses. Recent studies have shown that the antigen binding fragment (Fab) and Fc are involved in IgG-FcγRIII interactions. Here, we conducted bio-layer interferometry (BLI) and isothermal titration calorimetry to measure the kinetic and thermodynamic parameters that define the role of Fab in forming the IgG-FcγRIII complex using several marketed therapeutic antibodies. Moreover, hydrogen/deuterium exchange mass spectrometry (HDX-MS) and crosslinking mass spectrometry (XL-MS) were used to clarify the interaction sites and structural changes upon formation of these IgG-FcγRIII complexes. The results showed that Fab in IgG facilitates the interaction via slower dissociation and a larger enthalpy gain. However, a larger entropy loss led to only a marginal change in the equilibrium dissociation constant. Combined HDX-MS and XL-MS analysis revealed that the CL domain of Fab in IgG was in close proximity to FcγRIIIa, indicating that this domain specifically interacts with the extracellular membrane-distal domain (D1) and membrane-proximal domain (D2) of FcγRIIIa. Together with previous studies, these results demonstrate that IgG-FcγRIII interactions are predominantly mediated by the binding of Fc to D2, and the Fab-FcγRIII interaction stabilizes complex formation. These interaction schemes were essentially fucosylation-independent, with Fc-D2 interactions enhanced by afucosylation and the contribution of Fab slightly reduced. Furthermore, the influence of antigen binding on IgG-FcγRIII interactions was also investigated. Combined BLI and HDX-MS results indicate that structural alterations in Fab caused by antigen binding facilitate stabilization of IgG-FcγRIII interactions. This report provides a comprehensive understanding of the interaction between IgG and FcγRIII.

Citing Articles

In Vitro Evaluation of Genetically Unmodified Ligand-Armed Allogeneic Natural Killer Cells to Treat EGFR-Positive Glioblastoma.

Courot H, Rigal E, Adib N, Criton M, Cookson A, Fauvel B Cells. 2025; 14(4).

PMID: 39996727 PMC: 11854314. DOI: 10.3390/cells14040254.


Quantifying antibody binding: techniques and therapeutic implications.

Lodge J, Kajtar L, Duxbury R, Hall D, Burley G, Cordy J MAbs. 2025; 17(1):2459795.

PMID: 39957177 PMC: 11834528. DOI: 10.1080/19420862.2025.2459795.


Underappreciated layers of antibody-mediated immune synapse architecture and dynamics.

Goldberg B, Ackerman M mBio. 2024; 16(1):e0190024.

PMID: 39660921 PMC: 11708040. DOI: 10.1128/mbio.01900-24.


Systematic Preparation of a 66-IgG Library with Symmetric and Asymmetric Homogeneous Glycans and Their Functional Evaluation.

Manabe S, Iwamoto S, Nagatoishi S, Hoshinoo A, Mitani A, Sumiyoshi W J Am Chem Soc. 2024; 146(33):23426-23436.

PMID: 39106493 PMC: 11345770. DOI: 10.1021/jacs.4c06558.


Generation of non-genetically modified, CAR-like, NK cells.

Coenon L, Rigal E, Courot H, Multrier C, Zemiti S, Lambour J J Immunother Cancer. 2024; 12(7).

PMID: 39029925 PMC: 11261687. DOI: 10.1136/jitc-2024-009070.


References
1.
Matsumiya S, Yamaguchi Y, Saito J, Nagano M, Sasakawa H, Otaki S . Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J Mol Biol. 2007; 368(3):767-79. DOI: 10.1016/j.jmb.2007.02.034. View

2.
Al Qaraghuli M, Kubiak-Ossowska K, Ferro V, Mulheran P . Antibody-protein binding and conformational changes: identifying allosteric signalling pathways to engineer a better effector response. Sci Rep. 2020; 10(1):13696. PMC: 7426963. DOI: 10.1038/s41598-020-70680-0. View

3.
Diebolder C, Beurskens F, de Jong R, Koning R, Strumane K, Lindorfer M . Complement is activated by IgG hexamers assembled at the cell surface. Science. 2014; 343(6176):1260-3. PMC: 4250092. DOI: 10.1126/science.1248943. View

4.
Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O . Highly accurate protein structure prediction with AlphaFold. Nature. 2021; 596(7873):583-589. PMC: 8371605. DOI: 10.1038/s41586-021-03819-2. View

5.
van Zundert G, Rodrigues J, Trellet M, Schmitz C, Kastritis P, Karaca E . The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. J Mol Biol. 2015; 428(4):720-725. DOI: 10.1016/j.jmb.2015.09.014. View